- Home
- / Golden Biotechnology
Golden Biotechnology
Stock Price
NT$18
2024-10-29
Market Capitalization
NT$2.9 B
2024-10-29
Revenue
NT$40.9 M
FY, 2024
Golden Biotechnology Summary
Company Summary
- Overview
- Golden Biotechnology is a company that manufactures drugs and healthy food supplements. It offers products for liver health support and fatigue, recovery from illness, pancreatic cancer treatment, etc.
- Type
- Public
- Status
- Active
- Founded
- 2002
- Cybersecurity rating
Table of Contents
Golden Biotechnology Financials
Summary Financials
- Revenue (H1, 2025)
- NT$26.6M
- Gross profit (H1, 2025)
- NT$20.8M
- Net income (H1, 2025)
- (NT$115.0M)
- Cash (H1, 2025)
- NT$61.0M
- EBIT (H1, 2025)
- (NT$108.2M)
- Enterprise value
- $3.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026